APMA congratulates the Iowa Podiatric Medical Society (IPMS) on the enactment of HF 2498, legislation adopting the Interstate Podiatric Medical Licensure Compact (IPMLC) in the state. Governor Kim Reynolds recently signed the bill into law, making Iowa the second state to join the compact.
APMA congratulates the Colorado Foot & Ankle Society (CFAS) on the successful enaction of HB 26-1344, which preserves the independent Colorado Podiatry Board following the state’s sunset review process. APMA supported these efforts by submitting a formal letter to lawmakers outlining concerns related to workforce impacts, patient safety, and the importance of specialty-specific oversight for podiatric physicians.
CMS is now accepting exception applications for the 2026 Merit-based Incentive Payment System performance year. Clinicians affected by circumstances beyond their control, such as natural disasters, public health emergencies, or cyberattacks, may be eligible for a MIPS exception and reweighting of performance categories.
APMA recently urged the Department of State and Department of Homeland Security to explicitly include Doctors of Podiatric Medicine (DPMs) and podiatric residents in physician-focused immigration prioritization and expedited processing policies.
APMA has officially launched its new eAdvocacy Action Center for members, patients and students to engage in grassroots advocacy. The platform empowers APMA members to quickly engage their members of Congress and influence federal health policy. It also provides tools to take action on critical state legislation.
Representatives and APMA staff participated in a robust discussion of payer utilization management practices, modifier advocacy, including the new 25 Modifier Progress Note Guidance, the evolving use of AI in payment review and denial, Medicare Administrative Contractor (MAC) engagement, skin substitute reimbursement concerns, and Durable Medical Equipment (DME) issues.
The House Energy and Commerce Health Subcommittee is hosting a hearing on May 20 titled Examining the Medicare Physician Fee Schedule, MACRA, and Opportunities for Payment Reforms. The hearing will focus on bipartisan opportunities to reform the Medicare Physician Fee Schedule (MPFS) and Merit-Based Incentives Payment System (MIPS).
Samuel Gorelik, DPM, recently attended a Massachusetts town hall hosted by Representative Seth Moulton (D-MA), where he discussed the importance of the Diabetes Foot Health Access and Modernization Act. Representative Moulton cosponsored the legislation the very next day.
Representatives Mariannette Miller-Meeks, MD (R-IA), and Herb Conaway, MD (D-NJ), introduced the Medicare Physician Data-driven Performance Payment System Act, which would reform the Merit-based Incentive Payment System (MIPS) in Medicare. The legislation would replace MIPS with the Data-Driven Performance Payment System (DPPS), which would lower physician payment penalties and reinvest penalty funds to assist under-resourced practices.
CMS updated the WISeR Provider and Supplier Operational Guide to remove ICD-10 codes L97.111-L97.826 from Appendix B as indications that would automatically trigger prior authorization or pre-payment review for skin substitute applications. These diagnosis codes are commonly used to describe non-pressure chronic ulcers of the lower limb and are not exclusive to DFUs or VLUs.
APMA continues to engage in advocacy efforts through our coalition work with the Alliance for Wound Care Stakeholders, particularly on issues related to skin substitutes and physician payment. During the first quarter of 2026, the alliance supported APMA’s ongoing effort related to the revised NPU episode-based cost measure.
APMA submitted a letter responding to the House Committee on Ways and Means Health Subcommittee for a field hearing on modernizing healthcare practices for chronic condition treatment.
APMA is proud to acknowledge the founding members of the APMA Corporate Council: Amgen, Clutch Medical, NextGen Healthcare, PICA, Sagis Diagnostics, and Vertex Pharmaceuticals. This initiative will increase collaboration between APMA leadership, members, and key leaders across the podiatric profession.
In the Medicare Advantage Risk Adjustment Data Validation Final Rule released earlier this month, Medicare Advantage plans are now disallowed from counting diagnoses that are derived only from chart review and are not linked to any service provided to the patient toward the Medicare Advantage risk scores and payments.
APMA submitted a follow up letter to the Medicare Payment Advisory Commission (MedPAC), calling for doctors of podiatric medicine (DPMs) to be consistently classified as physicians in all MedPAC reports and analyses.
APMA has updated its Medicaid Toolkit with a new resource on the Medicaid-related provisions in the One Big Beautiful Bill Act (OBBBA). The toolkit equips members with practical advocacy resources, including a 50-state coverage survey, legislator talking points, fact sheets, Medicaid maps, eAdvocacy tools, and more.
APMA hosted a congressional briefing to highlight the importance of passing the Diabetes Foot Health Access and Modernization Act. Congressional staffers heard from panelists on the current barriers prescribing and furnishing therapeutic shoes in Medicare, highlighting how the provisions of the legislation would improve patient outcomes, reduce health-care costs, and improve timely access to diabetic care.
APMA congratulates the Iowa Podiatric Medical Society on the passage of HF 2498, legislation to adopt the Interstate Podiatric Medical Licensure Compact (IPMLC) in Iowa.
APMA urged CMS to update and improve the feedback reports clinicians receive after each MIPS performance year. Specifically, APMA recommended that the annual reports deliver performance feedback in a clear, interpretable, and actionable format.
Following sustained advocacy CMS confirmed that co-signed notes are not required for coverage of diabetic shoes/inserts when other specific documentation standards are met. APMA also requested that CMS publicize this confirmation, which it did with a newly published article.